These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12661920)

  • 1. Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats.
    Fujioka Y; Masai M; Tsuboi S; Okumura T; Morimoto S; Tsujino T; Ohyanagi M; Iwasaki T
    Hypertens Res; 2003 Jan; 26(1):111-6. PubMed ID: 12661920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Na+/H+ exchanger is associated with hyperinsulinemia in borderline hypertensive rats.
    Masai M; Fujioka Y; Fujiwara M; Morimoto S; Miyoshi A; Suzuki H; Iwasaki T
    Eur J Clin Invest; 2001 Mar; 31(3):193-200. PubMed ID: 11264645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats.
    Inoue I; Takahashi K; Katayama S; Harada Y; Negishi K; Itabashi A; Ishii J
    Metabolism; 1995 Dec; 44(12):1626-30. PubMed ID: 8786734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
    Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
    J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
    Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
    Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells.
    de Dios ST; Hannan KM; Dilley RJ; Hill MA; Little PJ
    J Diabetes Complications; 2001; 15(3):120-7. PubMed ID: 11358680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
    Chen S; Noguchi Y; Izumida T; Tatebe J; Katayama S
    J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of troglitazone and vitamin E on the fatty acid composition of serum phospholipids in an experimental model of insulin resistance.
    Chvojková S; Kazdová L; Divisová J
    Physiol Res; 2001; 50(3):261-6. PubMed ID: 11521736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against a role of insulin in hypertension in spontaneously hypertensive rats. CS-045 does not lower blood pressure despite improvement of insulin resistance.
    Katayama S; Abe M; Kashiwabara H; Kosegawa I; Ishii J
    Hypertension; 1994 Jun; 23(6 Pt 2):1071-4. PubMed ID: 8206597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats.
    Si X; Webb RC; Richey JM
    Can J Physiol Pharmacol; 1999 Oct; 77(10):755-62. PubMed ID: 10588479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.
    Ackerman Z; Oron-Herman M; Grozovski M; Rosenthal T; Pappo O; Link G; Sela BA
    Hypertension; 2005 May; 45(5):1012-8. PubMed ID: 15824194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic T-type Ca2+ channel blockade with mibefradil in hyperinsulinemic, insulin-resistant and hypertensive rats.
    Verma S; Bhanot S; Hicke A; McNeill JH
    Cardiovasc Res; 1997 Apr; 34(1):121-8. PubMed ID: 9217881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-arginine on blood pressure and metabolic changes in fructose-hypertensive rats.
    Tay A; Ozçelikay AT; Altan VM
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):72-7. PubMed ID: 11824864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
    Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
    Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic actions of insulin and troglitazone on contractility in endothelium-denuded rat aortic rings.
    Goud C; Pitt B; Webb RC; Richey JM
    Am J Physiol; 1998 Nov; 275(5):E882-7. PubMed ID: 9815009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fat-induced increase in blood pressure and insulin resistance in rats.
    Yoshioka S; Uemura K; Tamaya N; Tamagawa T; Miura H; Iguchi A; Nakamura J; Hotta N
    J Hypertens; 2000 Dec; 18(12):1857-64. PubMed ID: 11132611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fructose and troglitazone on phospholipid fatty acid composition in rat skeletal muscle.
    Clore JN; Li L; Rizzo WB
    Lipids; 2000 Nov; 35(11):1281-7. PubMed ID: 11132187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salt-loading elevates blood pressure and aggravates insulin resistance in Wistar fatty rats: a possible role for enhanced Na+ -H+ exchanger activity.
    Hayashida T; Ohno Y; Otsuka K; Suzawa T; Shibagaki K; Suzuki H; Ikeda H; Saruta T
    J Hypertens; 2001 Sep; 19(9):1643-50. PubMed ID: 11564985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.